Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
- PMID: 21122968
- DOI: 10.1016/j.joms.2010.06.200
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Abstract
Purpose: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a severe and therapy-resistant disease. The present study was performed to evaluate the role of the duration of preoperative antibiotic therapy within an otherwise standardized treatment protocol of patients with BRONJ stages I and II. One group of patients received a short-term preoperative antibiotic regime (A-ST) and the other a long-term preoperative antibiotic regime (B-LT).
Patients and methods: A retrospective chart review was used to analyze 46 patients with BRONJ from 2004 to 2009 who were treated with the same surgical technique and the same postoperative antibiotic treatment. Ten patients were classified as stage I, and 37 as stage II. All patients had intravenous bisphosphonate therapy in their case histories. Surgical treatment included an extended surgical procedure with sequestrectomy, bone smoothing, tension-free tissue covering, and drainage, with attention to neighboring teeth. After surgery, antibiotics were given (median) for 7 days intravenously and orally for another 10 to 12 days. Only patients who fulfilled these criteria were included in the retrospective chart review. In group A-ST 16 patients with 17 operations received antibiotics for 1 to 8 days before operation, whereas in group B-LT 30 patients had preoperative therapy of 23 to 54 days. Postoperative clinical examination followed a standardized protocol. Complete healing with intact soft tissue coverage was regarded as a success.
Results: The mean follow-up in both groups was 17.4 months (median, 11.5 months). Within the overall observation period, only 35% of patients in group A-ST and 70% in group B-LT showed complete healing, but at the time of the last clinical examination, 53% in group A-ST and 87% in group B-LT were free of soft tissue dehiscence. A certain number of soft tissue dehiscences within the observation period could clearly be related to later tooth extractions or pressure sores of dentures; excluding these interfering problems, 47% in group A-ST and 87% in group B-LT were treated successfully. Differences between these groups were significant.
Conclusions: This study indicates that surgical treatment in patients with stage I BRONJ and especially in those with stage II BRONJ in combination with a long-term preoperative antibiotic treatment can lead to a complete healing in 70% to 87% of cases in contrast to 35% to 53% with a short-term regime. The higher success rate after prolonged preoperative antibiotic therapy may be linked to an infectious role in BRONJ etiology requiring adequate treatment. Antibiotics may effectively treat neighboring lightly infected bone, whereas surgery removes the irreversibly infected and necrotic bone. To achieve complete healing, an extended surgical procedure in combination with local mouth rinses and prolonged antibiotic therapy can be recommended for treatment of BRONJ.
Copyright © 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):195-202. doi: 10.1016/j.tripleo.2011.02.037. Epub 2011 May 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011. PMID: 21622014
-
Surgical management of bisphosphonate induced osteonecrosis of the jaws.Int J Oral Maxillofac Surg. 2010 Mar;39(3):251-5. doi: 10.1016/j.ijom.2009.11.014. Epub 2009 Dec 16. Int J Oral Maxillofac Surg. 2010. PMID: 20015614
-
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Nov;110(5):593-6. doi: 10.1016/j.tripleo.2010.05.067. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20955948
-
Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.J Oral Maxillofac Surg. 2009 May;67(5 Suppl):44-52. doi: 10.1016/j.joms.2008.12.004. J Oral Maxillofac Surg. 2009. PMID: 19371814 Review.
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
Cited by
-
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options.Int J Mol Sci. 2024 Jul 24;25(15):8053. doi: 10.3390/ijms25158053. Int J Mol Sci. 2024. PMID: 39125621 Free PMC article. Review.
-
Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.Oral Dis. 2019 May;25(4):1116-1135. doi: 10.1111/odi.13052. Epub 2019 Feb 19. Oral Dis. 2019. PMID: 30712276 Free PMC article.
-
The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report.J Lasers Med Sci. 2020 Winter;11(1):98-103. doi: 10.15171/jlms.2020.16. Epub 2020 Jan 18. J Lasers Med Sci. 2020. PMID: 32099634 Free PMC article.
-
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8. Int J Oral Sci. 2014. PMID: 25105817 Free PMC article.
-
Cerebral and Intra-ventricular Abscess Caused by Bisphosphonate-related Osteonecrosis of the Jaw (BRONJ).NMC Case Rep J. 2015 Sep 8;3(2):25-27. doi: 10.2176/nmccrj.cr.2015-0066. eCollection 2016 Apr. NMC Case Rep J. 2015. PMID: 28663992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical